Stockreport

Foghorn Therapeutics Announces Upcoming Investor Conference Participation [TheStreet.com]

Foghorn Therapeutics Inc.  (FHTX) 
PDF CAMBRIDGE, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medic [Read more]